Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Kavin Fatehchand"'
Autor:
Kavin Fatehchand, Ramasamy Santhanam, Brenda Shen, Ericka L Erickson, Shalini Gautam, Saranya Elavazhagan, Xiaokui Mo, Tesfaye Belay, Susheela Tridandapani, Jonathan P Butchar
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0181729 (2017)
Active Hexose Correlated Compound (AHCC) has been shown to have many immunostimulatory and anti-cancer activities in mice and in humans. As a natural product, AHCC has potential to create safer adjuvant therapies in cancer patients. Acute Myeloid Leu
Externí odkaz:
https://doaj.org/article/6f940099867e4baa8929e7abfbcec91d
Autor:
Hafza Inshaar, Giovanna Merchand-Reyes, Nathaniel J Buteyn, Kavin Fatehchand, Christopher B Colvin, Xiaokui Mo, Brenda Shen, Jonathan P. Butchar, Susheela Tridandapani, Bethany L. Mundy-Bosse, Payal Mehta, Ramasamy Santhanam
Publikováno v:
Oncotarget
Acute myeloid leukemia (AML) is characterized by the proliferation of immature myeloid blasts and a suppressed immune state. Interferons have been previously shown to aid in the clearance of AML cells. Type I interferons are produced primarily by pla
Autor:
Robert Pilarski, Mohamed H. Abdel-Rahman, Kavin Fatehchand, Colleen M. Cebulla, Frederick H. Davidorf
Uveal melanoma (UM) is the most common primary intraocular malignancy in adults. Known risk factors for the risk of UM development include white race, blue/green iris eye color, older age, and some environmental risk, in particular arc welding. UM re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1b7caf11104a4464c98144dea51f236
https://doi.org/10.1016/b978-0-12-816222-4.00009-5
https://doi.org/10.1016/b978-0-12-816222-4.00009-5
Autor:
Mohamed H. Abdel-Rahman, Elizabeth D. Au, Milam A. Brantley, Kinga M. Bujakowska, Colleen M. Cebulla, Rui Chen, Jessica N. Cooke Bailey, Frederick H. Davidorf, Eiko K. de Jong, Anneke I. den Hollander, Rachayata Dharmat, Patty P.A. Dhooge, Michael H. Farkas, Kavin Fatehchand, John H. Fingert, Xiaoyi Raymond Gao, Maartje J. Geerlings, Jonathan L. Haines, Carel B. Hoyng, Robert P. Igo, Hacer Isildak, Tadeusz J. Kaczynski, Mariam Lotfy Khaled, Yutao Liu, Leighanne R. Main, Matthew A Miller, Matthew P. Ohr, Robert Pilarski, Emily Place, Claudio Punzo, Riccardo Sangermano, Stephen G. Schwartz, Hilary Scott, Ruifang Sui, Dyon Valkenburg, Carly J. van der Heide, Naomi Wagner, Andrea R. Waksmunski, Hui Wang, Katie Weihbrecht, Hannah Youngblood
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f5cb6c321243789bb397ae4989ac126
https://doi.org/10.1016/b978-0-12-816222-4.09992-5
https://doi.org/10.1016/b978-0-12-816222-4.09992-5
Autor:
Amanda Campbell, Brenda F. Reader, Payal Mehta, Saranya Elavazhagan, Andrew Stiff, Shalini Gautam, Huiqing Fang, Jonathan P. Butchar, Kavin Fatehchand, Xiaokui Mo, Li Ren, John C. Byrd, Susheela Tridandapani, William E. Carson
Publikováno v:
Journal of Biological Chemistry. 291:3043-3052
The irreversible Bruton's tyrosine kinase (Btk) inhibitor ibrutinib has shown efficacy against B-cell tumors such as chronic lymphocytic leukemia and B-cell non-Hodgkin lymphoma. Fcγ receptors (FcγR) on immune cells such as macrophages play an impo
Autor:
Kavin Fatehchand, Gregory N. Dietsch, Saranya Elavazhagan, Jonathan P. Butchar, Huiqing Fang, Robert M. Hershberg, Susheela Tridandapani, Xiaokui Mo, Li Ren, John P. Vasilakos
Publikováno v:
Journal of Biological Chemistry. 291:3895-3904
Monocytes and macrophages are critical for the effectiveness of monoclonal antibody therapy. Responses to antibody-coated tumor cells are largely mediated by Fcγ receptors (FcγRs), which become activated upon binding to immune complexes. FcγRIIb i
The immune system plays an important role in the clearance of pathogens and tumor cells. However, tumor cells can develop the ability to evade immune destruction, making the interaction between the immune system and the tumor an important area of res
Autor:
Shalini Gautam, Jonathan P. Butchar, Susheela Tridandapani, Kavin Fatehchand, William E. Carson, Gino M Dettorre, Giovanna Merchand-Reyes, John C. Byrd, Sumithira Vasu, Bonnie K. Harrington, Ramasamy Santhanam, Sally E. Henderson, Don M. Benson, Huiqing Fang, Xiaokui Mo, Nathaniel J Buteyn
Acute myeloid leukemia (AML) remains a significant health problem, with poor outcomes despite chemotherapy and bone marrow transplants. Although one form of AML, acute promyelocytic leukemia (APL), is successfully treated with all-trans retinoic acid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0778cf37515e229f69cf8c4214436842
https://europepmc.org/articles/PMC6059202/
https://europepmc.org/articles/PMC6059202/
Autor:
John P. Vasilakos, Kavin Fatehchand, Huiqing Fang, Shalini Gautam, Jonathan P. Butchar, Saranya Elavazhagan, Brenda F. Reader, Xiaokui Mo, Robert M. Hershberg, Gregory N. Dietsch, Vikram Santhanam, John C. Byrd, Michael A. Caligiuri, Carolyn Cheney, Li Ren, Susheela Tridandapani, Edward L. Briercheck
Publikováno v:
The Journal of Immunology. 194:2786-2795
Fcγ receptors (FcγR) are critical mediators of monoclonal antibody cancer therapies, as they drive cytotoxic processes upon binding of effector cells to opsonized targets. Along with natural killer (NK) cells, monocytes are also known to destroy an
Autor:
Susheela Tridandapani, Ericka L. Erickson, Kavin Fatehchand, Saranya Elavazhagan, Ramasamy Santhanam, Tesfaye Belay, Xiaokui Mo, Brenda Shen, Shalini Gautam, Jonathan P. Butchar
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0181729 (2017)
PLoS ONE
PLoS ONE
Active Hexose Correlated Compound (AHCC) has been shown to have many immunostimulatory and anti-cancer activities in mice and in humans. As a natural product, AHCC has potential to create safer adjuvant therapies in cancer patients. Acute Myeloid Leu